Unitedhealth Group (UNH)

Mexico


	Symbol		Exchange		Currency
	UNH		NYSE		USD	Real-time
	UNH		CBOE Canada		CAD	Real-time
	UNH		Mexico		MXN	Delayed
	1UNH		Milan		EUR	Real-time
	UNH		Frankfurt		EUR	Delayed
	UNH		TradeGate		EUR	Delayed
	UNHm		Buenos Aires		ARS	Delayed
	UNHH34		B3		BRL	Delayed
	UNH		Vienna		EUR	Real-time
	UNH		Lima		USD	Delayed

Currency in MXN

10,905.01

-861.99(-7.33%)

Delayed Data10:55:28

Fair Value

Day's Range

10,800.00

10,905.01

52 wk Range

7,279.47

12,203.39

UNH Income Statement

Featured here, the Income Statement (earnings report) for Unitedhealth Group, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

242,155

257,141

287,597

324,162

371,622

Total Revenues Growth

+7.03%

+6.19%

+11.84%

+12.71%

+14.64%

Cost Of Revenues

184,557

190,141

217,945

244,545

280,664

Gross Profit

57,598

67,000

69,652

79,617

90,958

Gross Profit Growth

+6.97%

+16.32%

+3.96%

+14.31%

+14.24%

Gross Profit Margin %

23.79%

26.06%

24.22%

24.56%

24.48%

Other Operating Expenses, Total

37,913

44,595

45,682

51,182

58,600

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+3.87%	+17.62%	+2.44%	+12.04%	+14.49%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	35,193	41,704	42,579	47,782	54,628
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

19,685

22,405

23,970

28,435

32,358

Operating Income Growth

+13.5%

+13.82%

+6.99%

+18.63%

+13.8%

EBIT Margin %

8.13%

8.71%

8.33%

8.77%

8.71%

Net Interest Expenses

-1,704

-1,663

-1,660

-2,092

-3,246

Net Interest Expenses Growth

-21.71%

+2.41%

+0.18%

-26.02%

-55.16%

Interest Expense, Total

-1,704

-1,663

-1,660

-2,092

-3,246

Interest And Investment Income

-

-

-

-

-

Other Non Operating Expenses, Total

-

-

-

-

-

EBT, Excl. Unusual Items

17,981

20,742

22,310

26,343

29,112

Gain (Loss) On Sale Of Assets

-

-

-

-

-

Other Unusual Items, Total

-

-

-

-

-

EBT, Incl. Unusual Items

17,981

20,742

22,310

26,343

29,112

EBT, Incl. Unusual Items Growth

+12.78%

+15.36%

+7.56%

+18.08%

+10.51%

EBT, Incl. Unusual Items Margin

7.43%

8.07%

7.76%

8.13%

7.83%

Income Tax Expense

3,742

4,973

4,578

5,704

5,968

Net Income to Company

14,239

15,769

17,732

20,639

23,144

Minority Interest

-400

-366

-447

-519

-763

Net Income

13,839

15,403

17,285

20,120

22,381

Net Income Growth

+15.46%

+11.3%

+12.22%

+16.4%

+11.24%

Net Income Margin %

5.71%

5.99%

6.01%

6.21%

6.02%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

13,839

15,403

17,285

20,120

22,381

Basic EPS - Continuing Operations

14.55

16.23

18.33

21.47

24.12

Basic EPS - Continuing Operations Growth

+16.92%

+11.54%

+12.93%

+17.15%

+12.32%

Diluted EPS - Continuing Operations

14.33

16.03

18.08

21.18

23.86

Diluted EPS - Continuing Operations Growth

+17.56%

+11.86%

+12.79%

+17.15%

+12.65%

Basic Weighted Average Shares Outstanding

951

949

943

937

928

Diluted Weighted Average Shares Outstanding

966

961

956

950

938

Dividend Per Share

4.14

4.83

5.6

6.4

7.29

Dividend Per Share Growth

+20%

+16.67%

+15.94%

+14.29%

+13.91%

EBITDA

21,684

24,496

26,173

30,835

35,130

EBITDA Growth

+13.14%

+12.97%

+6.85%

+17.81%

+13.93%

EBITDA Margin %